STOCKWATCH
·
Pharmaceuticals
Partnership22 Jan 2026, 03:41 pm

Sequent Scientific's Subsidiary, Alivira Animal Health, Partners with Boehringer Ingelheim to Expand Companion Animal Portfolio in India

AI Summary

Alivira Animal Health Limited, a wholly owned subsidiary of Viyash Scientific Limited (formerly known as Sequent Scientific Limited), has entered into a partnership agreement with Boehringer Ingelheim India Private Limited for the distribution and promotion of their companion animal products portfolio in India. This partnership aims to capitalize on the growing opportunities in India’s pet healthcare market, driven by increased pet ownership, rising awareness of preventive care, and growing emphasis on animal well-being across the country. Alivira’s extensive geographical reach and on-ground capabilities, combined with Boehringer Ingelheim’s differentiated companion animal product portfolio, will strengthen their ability to serve veterinarians and pet parents across India effectively.

Key Highlights

  • Sequent Scientific's subsidiary, Alivira Animal Health, partners with Boehringer Ingelheim to expand companion animal portfolio in India.
  • Partnership aims to capture growing opportunities in India’s pet healthcare market.
  • Alivira’s extensive geographical reach and on-ground capabilities combined with Boehringer Ingelheim’s differentiated companion animal product portfolio.
  • India offers tremendous opportunities for innovative medicines which cater to the medical needs of pets.
  • Partnership designed to drive access to high-quality solutions for pets in urban and rural India.
SEQUENT
Pharmaceuticals
SEQUENT SCIENTIFIC LTD.

Price Impact